Offer to Purchase for Cash All Outstanding Shares of Common Stock of AveXis, Inc. at $218.00 Net Per Share by Novartis AM Merger Corporation an indirect wholly-owned subsidiary of NOVARTIS AG THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00...Offer to Purchase • April 17th, 2018 • Novartis Ag • Pharmaceutical preparations
Novartis AM Merger Corporation, a Delaware corporation ("Purchaser") and indirect wholly-owned subsidiary of Novartis AG, a company organized under the laws of Switzerland ("Parent"), is making an offer to purchase all outstanding shares (the "Shares") of common stock, par value $0.0001 per share (the "Common Stock"), of AveXis, Inc., a Delaware corporation ("AveXis" or the "Company"), at a price of $218.00 per Share, net to the seller in cash (such price, or any different price per Share as may be paid in the Offer, the "Offer Price"), without interest thereon and subject to any tax withholding, upon the terms and subject to the conditions set forth in this Offer to Purchase and the related Letter of Transmittal (which, together with any amendments or supplements thereto, collectively constitute the "Offer"). Purchaser is making the Offer pursuant to an Agreement and Plan of Merger, dated as of April 6, 2018 (the "Merger Agreement"), by and among Parent, Purchaser and AveXis. Followin
